Avanos Medical, Inc. (NYSE:AVNS) Holdings Boosted by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. boosted its holdings in Avanos Medical, Inc. (NYSE:AVNS) by 58.9% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 45,668 shares of the company’s stock after acquiring an additional 16,929 shares during the period. Connor Clark & Lunn Investment Management Ltd.’s holdings in Avanos Medical were worth $1,097,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of AVNS. Paradice Investment Management LLC raised its holdings in Avanos Medical by 5.4% during the second quarter. Paradice Investment Management LLC now owns 1,344,949 shares of the company’s stock worth $26,791,000 after purchasing an additional 69,389 shares in the last quarter. AQR Capital Management LLC raised its holdings in Avanos Medical by 21.0% during the second quarter. AQR Capital Management LLC now owns 146,983 shares of the company’s stock worth $2,875,000 after purchasing an additional 25,467 shares in the last quarter. Public Sector Pension Investment Board raised its holdings in Avanos Medical by 6.1% during the second quarter. Public Sector Pension Investment Board now owns 100,957 shares of the company’s stock worth $2,011,000 after purchasing an additional 5,793 shares in the last quarter. Federated Hermes Inc. raised its holdings in Avanos Medical by 4.2% during the second quarter. Federated Hermes Inc. now owns 97,097 shares of the company’s stock worth $1,934,000 after purchasing an additional 3,938 shares in the last quarter. Finally, American Century Companies Inc. raised its holdings in Avanos Medical by 12.1% during the second quarter. American Century Companies Inc. now owns 82,930 shares of the company’s stock worth $1,652,000 after purchasing an additional 8,929 shares in the last quarter. Institutional investors own 95.17% of the company’s stock.

Avanos Medical Trading Down 0.1 %

Avanos Medical stock opened at $19.14 on Thursday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. The firm has a market cap of $879.62 million, a price-to-earnings ratio of 56.35 and a beta of 0.92. Avanos Medical, Inc. has a 1 year low of $17.39 and a 1 year high of $25.36. The firm’s 50 day moving average price is $21.54 and its two-hundred day moving average price is $21.56.

Analyst Ratings Changes

Separately, StockNews.com cut Avanos Medical from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.